MedPath

Observational cohort study of clinically diagnosed unresectable pancreatic cancer patients; A multicenter retrospective, questionnaire analysis in Hokkaido Pancreatic Cancer Study Group (HOPS).

Not Applicable
Conditions
Pancreatic adenocarcinoma (PDAC), unresectable (UR)
Registration Number
JPRN-UMIN000035454
Lead Sponsor
Department of Surgery, Surgical Oncology and Science, Sapporo Medical University
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete: follow-up complete
Sex
All
Target Recruitment
66
Inclusion Criteria

Not provided

Exclusion Criteria

Patients who were defined as resectable (R-) or borderline resectable (BR-) by HOPS central MDCT review.

Study & Design

Study Type
Others,meta-analysis etc
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Conversion rate to radical surgeries
Secondary Outcome Measures
NameTimeMethod
Sequential treatment regimens and overall survival (OS)
© Copyright 2025. All Rights Reserved by MedPath